PHARM.ASSY
ActiveSummary
PHARM.ASSY has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €150k and a net result of €25k. Equity is growing by ~32.2% per year across the filed fiscal years. Its solvency ranks better than 68% of 18280 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability80▲+5
Solvency81▲+4
Growth61=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity ample (current ratio 1.86 against 2.66 in 2024; short-term debt: 34.2% and cash: 17.6% of total assets), and 44.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.6%
Return on assets
9.4%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
31 d late
2024
17 d early
2023
23 d early
2022
21 d late
2021
29 d late
2020
26 d late
2019
31 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€647k▲ 5.7%
2023 · €612k
2019: €707k
2020: €430k
2021: €480k
2022: €546k
2023: €612k
2019 → 2024
EBIT margin
5.9%=
2023 · 5.9%
2019: 1.8%
2020: 0.8%
2021: 6.3%
2022: 4.9%
2023: 5.9%
2019 → 2024
Net result
€25k▼ 3.1%
2024 · €26k
2019: €680
2020: €13k
2021: €23k
2022: €16k
2023: €27k
2024: €26k
2019 → 2025
Working capital
€79k▼ 25.6%
2024 · €107k
2019: €-6k
2020: €2k
2021: €27k
2022: €44k
2023: €81k
2024: €107k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€480k-€546k▲ 13.7%€612k▲ 12.1%€647k▲ 5.7%
Equity€56k-€72k▲ 29.3%€99k▲ 37.6%€125k▲ 26.3%€150k▲ 19.8%
Operating result€30k-€27k▼ 10.7%€36k▲ 34.0%€38k▲ 5.9%€40k▲ 4.3%
Net result€23k-€16k▼ 30.2%€27k▲ 65.9%€26k▼ 3.9%€25k▼ 3.1%
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 4% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €269k
Fixed assets
€98k ▲ 37.7%
Current assets
€171k ▲ 0.1%
Equity and liabilities €269k
Equity
€150k ▲ 19.8%
Debt
€119k ▲ 1.9%
Debt's share of the balance-sheet total falls from 48.4% to 44.4%. Equity and debt are higher.
Key figures and ratios
EBITDA
€68k▲
2024 · €64k
Cash flow
€53k▲
2024 · €52k
Current ratio
1.86▼
2024 · 2.66
Quick ratio
0.90▼
2024 · 1.31
Debt to equity
0.80▼
2024 · 0.94
ROE
16.8%▼
2024 · 20.8%
ROA
9.4%▼
2024 · 10.7%
Interest coverage
23.02▲
2024 · 12.26
Debt ≤ 1 year
€92k▲
2024 · €64k
Debt > 1 year
€27k▼
2024 · €53k
Income taxes
€14k▲
2024 · €11k
Staff costs
€32k▲
2024 · €31k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 57 lines
Balance sheet
Code20242025
Assets
Total assets20/58€242k€269k▲
Fixed assets21/28€71k€98k▲
Intangible fixed assets21€59k€41k▼
Tangible fixed assets22/27€11k€56k▲
Plant, machinery and equipment23€796€0▼
Furniture and vehicles24€10k€6k▼
Other tangible fixed assets26-€49k
Financial fixed assets28€1k€1k=
Current assets29/58€171k€171k▲
Stocks and contracts in progress3€87k€89k▲
Stocks30/36€87k€89k▲
Amounts receivable within one year40/41€39k€35k▼
Trade receivables40€37k€35k▼
Other amounts receivable41€2k€21▼
Cash at bank and in hand54/58€45k€47k▲
Equity and liabilities
Total equity and liabilities10/49€242k€269k▲
Equity10/15€125k€150k▲
Contributions10/11€19k€19k=
Capital10€19k-
Issued capital100€19k-
Reserves13€2k€22k▲
Non-distributable reserves130/1€2k€2k=
Legal reserve130€2k-
Reserves not available under the articles1311-€2k
Distributable reserves133-€20k
Profit (loss) carried forward14€105k€109k▲
Amounts payable17/49€117k€119k▲
Amounts payable after more than one year17€53k€27k▼
Financial debts170/4€53k€27k▼
Amounts payable within one year42/48€64k€92k▲
Current portion of amounts payable after more than one year42€26k€25k▼
Trade debts44€20k€30k▲
Suppliers440/4€20k€30k▲
Taxes, remuneration and social security45€15k€32k▲
Taxes450/3€10k€25k▲
Remuneration and social security454/9€5k€7k▲
Other amounts payable47/48€3k€4k▲
Income statement
Code20242025
Turnover70€647k-
Goods, raw materials, services and sundry goods60/61€550k-
Remuneration, social security and pensions62€31k€32k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26k€28k▲
Other operating charges640/8€660€1k▲
Gross operating margin9900€96k€101k▲
Operating profit (loss)9901€38k€40k▲
Financial income75/76B€4k€3k▼
Recurring financial income75€4k€3k▼
Financial charges65/66B€5k€3k▼
Recurring financial charges65€5k€3k▼
Profit (loss) for the period before taxes9903€37k€40k▲
Income taxes67/77€11k€14k▲
Profit (loss) for the period9904€26k€25k▼
Profit (loss) for the period to be appropriated9905€26k€25k▼
Appropriation of the result
Profit (loss) to be appropriated9906€105k€129k▲
Profit (loss) brought forward from the previous period14P€79k€104k▲
Transfer to equity691/2-€20k
To other reserves6921-€20k
Social balance
Average headcount (FTE)90871.0-
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
14-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Equity above €100kEq €125k ▲26.3%
6 profitable years in a row build equity to €125k.
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Highest result since 2019net €27k ▲65.9%
Net result €27k, the highest in the series.
21-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 21 days late
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 29 days late
2021
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 26 days late
2020
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wemmel · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Steenweg op Merchtem 331780 WemmelGround area
305 m²
Building footprint
122 m²
Volume, LiDAR
991 m³
Parcel 22005A0524/00L004, Flanders · tallest building 12.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Steenweg op Merchtem 33, 1780 Wemmel
since 20182.274.272.391
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22005A0524/00L004 | Flanders | 305 m² | 1 · 122 m² | 12.2 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Similar companies · same sector, comparable size
PHARM TG
BE 0775.535.190
Sambreville · Eq €149,752
Pharmacie B. CROWET
BE 0831.860.023
Binche · Eq €149,766
Apotheek Schreurs
BE 0568.596.776
Hasselt · Eq €149,847
DEVLIES PHARMA
BE 0877.804.765
Kortrijk · Eq €149,857
APOTHEEK VAN DER WEEEN
BE 0439.538.771
Denderleeuw · Eq €149,424
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,565 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded31-01-2018
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.